Regeneration of rabbit calvarial defects using cells-implanted nano-hydroxyapatite coated silk scaffolds by 이중석 et al.
Park et al. Biomaterials Research  (2015) 19:7 
DOI 10.1186/s40824-015-0027-1RESEARCH ARTICLE Open AccessRegeneration of rabbit calvarial defects using
cells-implanted nano-hydroxyapatite coated silk
scaffolds
Jin-Young Park1, Cheryl Yang1, Im-Hee Jung3, Hyun-Chang Lim1, Jung-Seok Lee1, Ui-Won Jung1,
Young-Kwon Seo2, Jung-Keug Park2 and Seong-Ho Choi1*Abstract
Background: The aim of this study was to characterize the efficacy of nano-hydroxyapatite-coated silk fibroin
constructs as a scaffold for bone tissue engineering and to determine the osteogenic effect of human dental pulp
and periodontal ligament derived cells at an early stage of healing in rabbits. 3D silk fibroin constructs were developed
and coated using nano-hydroxyapatite crystals. Dental pulp and periodontal ligament cells from extracted human third
molars were cultured and seeded onto the silk scaffolds prior to in vivo implantation into 8 male New Zealand White
rabbits. Four circular windows 8 mm in diameter were created in the calvarium of each animal. The defects were
randomly allocated to the groups; (1) silk scaffold with dental pulp cells (DPSS), (2) silk scaffold with PDL cells (PDLSS),
(3) normal saline-soaked silk scaffold (SS), and (4) empty control. The animals were sacrificed 2 (n = 4) or 4 weeks
(n = 4) postoperatively. The characteristics of the silk scaffolds before and after cell seeding were analyzed using
SEM. Samples were collected for histologic and histomorphometic analysis. ANOVA was used for statistical analysis.
Result: Histologic view of the experimental sites showed well-maintained structure of the silk scaffolds mostly
unresorbed at 4 weeks. The SEM observations after cell-seeding revealed attachment of the cells onto silk fibroin with
production of extracellular matrix. New bone formation was observed in the 4 week groups occurring from the periphery
of the defects and the silk fibers were closely integrated with the new bone. There was no significant difference in the
amount of bone formation between the SS group and the DPSS and PDLSS groups.
Conclusion: Within the limitations of this study, silk scaffold is a biocompatible material with potential expediency as
an osteoconductive scaffold in bone tissue engineering. However, there was no evidence to suggest that the addition
of hDPCs and hPDLCs to the current rabbit calvarial defect model can produce an early effect in augmenting
osteogenesis.
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Bone grafting has numerous applications in dentistry
such as alveolar ridge augmentation during implant ther-
apy and reconstructive surgeries involving large bone de-
fects. The preferred treatment is autograft, known to
produce the best clinical outcome due to its osteogenic
cellular component [1]; however, the use of autologous
bone has its limitations due to donor site morbidity,* Correspondence: shchoi726@yuhs.ac
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bone substitute materials of various organic and syn-
thetic origins are commercially manufactured and used
to provide the osteoconductive bulk upon which healing
at the cellular level can be induced. Tissue engineering
concepts have recognized the potential for graft mate-
rials to benefit from the addition of stem/progenitor
cells aimed at enhancing the rate and quality of defect
repair. According to the principles of tissue engineering,
elements of successful bone regeneration include osteo-
blastic progenitor cells, suitable growth factors and anis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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vascular network [4,5].
The ideal requirements of bone tissue engineering scaf-
folds include biocompatibility, appropriate chemistry,
morphology and structure to promote growth and differ-
entiation of osteoblastic progenitor cells for synthesis of
new bone matrix [5]. Silk fibroin is a promising biomate-
rial that has been used for both in vitro and in vivo appli-
cations due to the mechanical strength, biocompatibility,
and a slow degradation rate that enables gradual replace-
ment of fibroin with newly formed tissue [2]. Natural bone
extracellular matrix consists of a loose network of collagen
fibrils and hydroxyapatite crystals. Osteoconductive and
osteoinductive properties of the scaffold can be reinforced
by the addition of mineral hydroxyapatite (HA) due to its
structural similarities to natural bone extracellular matrix.
Incorporation of HA was shown not only to enhance the
surface characteristics of the scaffold by increasing its
roughness, but also promote viability of stem cells and
their proliferation [6].
Cytocompatibility of silk scaffold and the subsequent
formation of extracellular matrix onto silk fibroin have
been demonstrated previously [7]. Addition of a cellular
component may improve the osteoinductivity of a scaf-
fold and help to increase the speed of bone formation.
Various stem cells such as bone marrow stem cells, adi-
pose tissue-derived stem cells and embryonic stem cells
have been widely used in studies of bone tissue engin-
eering [8-10]. Bone marrow derived mesenchymal stem
cells (BMMSCs) in particular are the most studied, and
have been shown to be capable of differentiating into
multiple cell lineages including osteogenic, chondro-
genic, adipogenic, myelosupportive stroma, myogenic,
and neurogenic lineages. But due to certain shortcom-
ings of obtaining the BMMSCs including pain, morbid-
ity, and low cell number upon harvest, alternative
sources for MSCs have been sought. Dental tissues are
specialized tissues that do not undergo continuous re-
modeling; therefore dental tissue derived progenitor cells
may be more restricted in differentiation potency in
comparison to BMMSCs. Nevertheless, dental tissue de-
rived cells can be easily acquired from tooth extractions
and recent studies have proven dental stem cells to be a
potent source for fabrication of bone structures [11].
This is due to their good osteogenic activity potentially as
a result of their biological function to form hard mineral-
ized tissue during tooth development [11]. Dental pulp
stem cells (DPSCs) isolated from the dental pulp tissue
could differentiate into osteoblastic precursors under
stimulatory conditions, and were able to synthesize living
fibrous bone tissue in vitro. Furthermore, following trans-
plantation of the bone matrix into immunocompromised
rats, lamellar bone tissues containing osteocytes were gen-
erated [12]. Several studies have demonstrated successfuluse of DPSCs seeded in scaffolds. For example, porous cal-
cium phosphate ceramic discs [13], resorbable collagen
sponges [14,15] and poly(lactic-co-glycolic acid) copoly-
mers [16] have all been used to construct adequate cell-
scaffold matrices for in vivo transplantations.
Osteogenic differentiation of cultured periodontal liga-
ment stem cells (PDLSCs) has also been reported
[17-19]. In vivo transplantation of PDLSCs into peri-
odontal defects showed regeneration of the periodontal
tissues, identified to be closely related to the adjacent
trabecular bone, suggesting their involvement in alveolar
bone regeneration [17]. Subsequent studies containing
in vitro and in vivo experiments have shown use of
PDLSCs with bone tissue engineering scaffolds such as
nano-hydroxyapatite coated chitosan [20] and in vitro-
derived extracellular matrix [21].
In the present study, a collective population of cells
from the human dental pulp (DPCs) and periodontal
ligament (PDLCs) were isolated and cultured. The rabbit
calvarial defect model was used to evaluate the efficacy
of the SF construct for bone regeneration in vivo, and to
determine whether the addition of cellular component
may improve the rate and quality of defect repair.Methods
Preparation of silk scaffolds coated with nano-
hydroxyapatite
Silk sutures were purchased from Won Corporation
(Seoul, South Korea) and silk scaffolds were constructed
using a weaving machine. The silk scaffolds were proc-
essed by extracting sericin, a glue-like protein that coats
the native silk fibroin, using an aqueous solution con-
taining 0.02 M Na2CO3 and 0.3% Ivory detergent. 0.15 g
of nano-hydroxyapatite (Sigma) was dissolved in 10 ml
of PBS and 1ml of the solution was dried on the silk
scaffold (0.8×1.2 cm) in air. The scaffolds were then
soaked in a 1% type atelocollagen solution (Bioland,
Korea) and lyophilized in a freeze dryer (Samwon Freez-
ing Engineering Co., Korea) at −80°C for 48 h. The silk
scaffolds were incubated in 20 ml of 40% (v/v) ethanol
containing 50 mM 2-morpholineoehtane sulfonic acid
(MES, Fluka Chemic AG) (pH 5.5) for 30 min at room
temperature. The silk scaffolds were then immersed in 20
ml of 40% (v/v) ethanol containing 50 mM MES (pH 5.5),
24 mM 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide
(Fluka Chemic AG) and 5 mM N-hydroxysuccinimide
(Fluka Chemic AG) for 12 h at room temperature. Once
the reaction was complete, the composite silk scaffold was
washed twice in 0.1 M Na2HPO4 (pH9.0) for 12 h. The
scaffolds were washed twice in 1 M NaCl for 6 h, then in
2 M NaCl for 2 days and finally rinsed with distilled water.
The washed scaffolds were lyophilized again and sterilized
with γ-irradiation at 15 KGy.
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DPCs
Extracted third molars were used in experiments with the
approval of patients. The patients provided informed con-
sent for their tissue being used in accordance with guide-
lines approved by the Institutional Review Board, College
of Dentistry, Yonsei University (IRB No. 2-2010-0009).
The extracted third molars were washed with PBS con-
taining antibiotic antimycotic (AA) (Welgene, Korea) for 3
mins after washing with 70% ethanol. The third molars
were wavered with pliers and the dental pulp was re-
moved. The pulp tissues were digested in a solution of 3
mg/mL collagenase type I (Sigma St. Louis, Mo., USA)
and 4 mg/mL dispase (Siga, St. Louis, MO., USA) for 12 h
at 4°C. The pulp tissue was then incubated in 3 mL of
0.25% trypsin for 15 min at 37°C. After trypsin digestion,
the trypsin solution was diluted in alpha Modified Eagle’s
Medium (α-MEM, Sigma) containing 10% fetal bovine
serum (FBS, BioWhittakerTM, Cambrex, MD, USA). The
cells were isolated from the dental pulp by pipetting. After
centrifugation at 800 rpm for 5 min, the supernatant was
removed and added to 10 mL of α-MEM. The cell suspen-
sions were seeded in 100 mm culture dishes.
PDLCs
Human periodontal tissue was obtained from several ex-
tracted third molars of patients who had given their in-
formed consent (IRB No. 2-2010-0009). The extracted
third molars were washed with PBS containing antibiotic
antimycotic solution (AA) (Welgene, Korea) for 3 min
after washing with 70% ethanol.
The periodontal tissue was removed from the roots of
the teeth and then divided into small pieces with scissors
and tissues were digested in a solution of 3 mg/mL colla-
genase type I (Sigma, St. Louis, MO, USA) and 4 mg/mL
Protease (Sigma, P 3417, USA) for 12 h at 4°C. Then, PDL
tissues were incubated in 3 mL of 0.25% trypsin for 15
min at 37°C. After trypsin digestion, the trypsin solu-
tion was diluted with alpha Modified Eagle’s Medium
(α-MEM, Sigma) containing 10% fetal bovine serum
(FBS, BioWhittakerTM, Cambrex, MD, USA).
After centrifuging at 800 rpm for 5 min, the supernatant
was removed and pipetted with 10 mL of α-MEM. The
cell suspensions were seeded in 100 mm culture dish. The
PDL fibroblasts from third to five passages were used.
Seeding of cells in silk scaffolds
DPCs and PDLCs, suspended in alpha Modified eagle’s
Medium (α-MEM, Sigma) supplemented with 10% fetal
bovine serum (FBS, BioWhitekerTM, Cambrex Bioscience
Walkersville, Inc., MD), were seeded onto the silk scaffolds.
To obtain a very high cell seeding density, the cells were
seeded onto the silk scaffolds under a dried condition. 100
μl of a harvested suspension – containing 2.8 × 104 humandental pulp cells or 1 × 106 human PDL cells – and silk
scaffolds were placed in the petri dish in a humidified 5%
CO2 incubator, and 3h later, 10 ml of α-MEM was added
to the petri dish. The medium was replaced every 3 days
for 7 days. After incubation for additional 7 days, the scaf-
folds were cultured in differentiation medium, which was
replaced every 2 days for 3 weeks. The differentiation
medium for DPCs was alpha Modified Eagle’s Medium
(α-MEM, Sigma) supplemented with 10% fetal bovine
serum (FBS, BioWhittakerTM, Cambrex, MD, USA), 1%
AA, 100 nM dexamethasone, 0.05 mM Ascorbic acid
and 10 mM β-glycerophospate. The differentiation
medium for PDLCs was α-MEM containing 10% FBS, 10
mM β-glycerophosphate (Sigma), 50 μM L-ascorbate2-
phosphate (Sigma) and 10−7 M dexamethasone (Sigma).
The result of cell-seeding procedure was checked with
scanning electron microscopy.
Animals
Eight male New Zealand White rabbits weighing 2.8-3.2
kg and age 16–20 weeks were used in this study. Animal
selection and management, surgical protocol and prepar-
ation followed the routines approved by the Institutional
Animal Care and Use Committee, Yonsei Medical Center,
Seoul, Korea.
Study design
Four circular defects (8mm diameter) were created in
each animal, which were randomly allocated to the four
study groups including PDLC-silk scaffold group
(PDLSS group), DPC-silk scaffold group (DPSS group),
normal saline-soaked silk scaffold group (SS group) and
an empty control group. The animals were euthanized at
either 2 or 4 weeks postsurgery.
Surgical protocol
General anaesthesia was induced in all animals using
intramuscular injections of zoletil (15 mg/kg) and rompun
(5 mg/kg). The head of the rabbit was shaved and disin-
fected using povidone iodine prior to local anaesthetic in-
jections at the surgical site using 2.2 ml Lidocaine
Hydrochloride 2% with adrenaline 1:80,000. An incision
was made along the midline from the frontal bone to the
occipital bone and a full-thickness flap was elevated.
Under copious saline irrigation, four standardized round
defects 8 mm in diameter were created using a trephine
bur (Figure 1). The resected bones were removed carefully
to avoid injury to the underlying brain tissue. The defects
were filled with the experimental materials according to
the assigned group. The flaps were repositioned and su-
tured with resorbable suture material.
The animals were sacrificed at either 2 or 4 weeks
postsurgery. The skin flaps were reflected to expose the
Figure 1 Surgical procedure. A. Four standardized defects 8 mm in diameter were created using a trephine bur. B. The defects in each animal
were assigned into four groups. Clockwise from bottom left: sham control, silk scaffold (SS), dental pulp cells seeded on SS (DPSS), periodontal
ligament cells seeded on SS (PDLSS). C. The silk scaffold was made at 8 mm in diameter in order to fit into the defects.
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harvested from each animal.
Histologic processing
Block sections of the surgical sites were fixed in 10% for-
malin for 10 days. The fixed specimens were decalcified
in 5% formic acid for 14 days and then embedded in par-
affin. Serial 5 μm thick sections were cut along the mid-
line of the calvarial defects. Only sections located at the
middle of the defects were selected, and stained with
hematoxylin-eosin for histologic and histometric analysis.
Analysis methods
Histomorphometric analysis
After the conventional microscopic examination,
computer-assisted histometric measurements in the cal-
varial defect were performed using an automated image
analysis system (Image-Pro Plus; Media Cybernetics, Silver
Spring, MD). The following parameters were measured
from each histologic section of the defect areas.
 Total augmented area (mm2) – Total sum of the
area of new bone, residual particles, connective
tissue, adipose tissue, blood vessels within the defect
area.
 Residual material (mm2) – Area of the remaining
silk scaffold within the defect.
 New bone (mm2) – Area of newly formed bone
within the defect.
Statistical analysis
The statistical analysis was performed using a commercially
available software program (SPSS 18.0, SPSS, Chicago, IL).
Histomorphometric records from the calvarial defect sam-
ples were used to calculate the mean and standard devi-
ation (SD) values of groups. One-way analysis of variance
(ANOVA) was used to analyze the difference between the
groups at 2 and 4 weeks. Statistical significance was consid-
ered when P <0.05.
SEM observations
The morphology of nHA-coated scaffolds before and
after the cell-seeding procedure were observed byscanning electron microscopy (SEM; S-3000N, Hitachi,
Tokyo, Japan) at an accelerating voltage of 30 kV.Clinical and histological findings
Throughout the healing periods, the animals were care-
fully monitored for adverse reactions around the surgical
site. The specimens were examined by a single, blinded
examiner with the aid of a binocular microscope (DM
LB, Leica Microsystems, Wetzlar, Germany) equipped
with a camera (DC300F, Leica Microsystems). Images of
the slides were acquired and saved as digital files.Results
SEM observations of nHA-coated silk scaffolds
SEM observations of the surface of the nHA-coated silk
scaffold revealed a combination of porous architecture
of the silk fibroin. A closer examination at a higher mag-
nification revealed organization of the fibrous structures
into bundles. Cross-sectional view revealed intercon-
nected porous structure of the silk fibroin construct.
Pore sizes varied between 20–80 μm with mean pore
diameter of 65 μm (Figure 2A). Longitudinal sections
showed an internal structure with fibrous bundles
mainly oriented parallel to the scaffold surface.
At 400 magnification view (Figure 2C, D) homogenous
distribution of nano-HA crystals on pure silk fiber sub-
strates can be observed as small round granules. In
parts, nHA crystals displayed formation of clusters with
attachment of the cellular matrix. The implanted cells
were well spread out and attached to the surfaces of
scaffolds. Also, the formation of an ECM was observed.
This is a typical response that is indicative of cytocom-
patibility and adaptation of the cells onto silk fibroin.Clinical findings
Healing of all surgery sites was without any adverse re-
actions or postoperative complications such as abnormal
bleeding or infection. Signs of inflammation such as
swelling appeared to be minimal, and the grafted mate-
rials were confirmed to be intact within the defects at
the time of sacrifice and sample collection.
Figure 2 Scanning electron microscopy images. A and B shows the cross section and longitudinal section of the silk scaffold respectively prior to
the cell culture. Porous, interconnected structure can be observed, ×100 magnification. C and D show the cross section and longitudinal section of the
silk scaffold respectively, following the cell culture, ×400 magnification. Arrows represent spreading of the cells with secreted extracellular matrix on
the silk fibroin. Arrowheads represent nHA crystals on silk fibroin.
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In the control group, negligible amount of new bone for-
mation was observed. The defect spaces were filled by
the underlying brain tissues as well as the overlying peri-
osteum that was collapsed into the vacant space.
In DPSS, PDLSS and SS groups, the silk fibroin con-
structs occupied the defect spaces and exhibited well-
maintained structure in all sites. The scaffolds were
superficially covered by the overlying periosteum and the
silk fibers were surrounded by the connective tissue of
ECM comprising loose collagen network stained by the
light blue coloration of Masson’s trichrome staining.
At 2 weeks, the interconnected porous structures were
occupied by the inflammatory cells mainly macrophages,
which were evenly distributed (Figure 3). The scaffold
showed compact arrangement of silk fibers organized intoFigure 3 Histological view of the groups at 2 weeks postoperatively.
groups showing inflammatory cells mainly macrophages evenly distributed abundles and blood vessels formed vascular networks
around the bundles of silk fibroin. Minimal new bone for-
mation was observed (Figure 4).
At 4 weeks, the inflammatory cells no longer existed
around the fibrous network. Angiogenesis had occurred
surrounding the fibrous bundles evident by the appearance
of blood vessels, however none were seen to penetrate the
internal structure of the porous network. ECM appeared
visibly denser than at 2 weeks and early new bone forma-
tion was observed occurring mainly from the periphery of
the defects. The newly formed bone was seen to be in close
contact with the individual fibers of silk scaffold (Figure 5).
Histomorphometric analysis revealed no statistical sig-
nificance between DPSS, PDLSS and SS groups in terms
of the area of new bone (Table 1, Figure 6). However,
the total augmented area showed to be significantlyA – DPSS group, B – PDLSS group, C – SS group. All experimental
round the silk scaffold. ×200 magnification, Mason’s trichrome staining.
Figure 4 Histological view of the groups at 2 weeks postoperatively. A –control group shows negligible amount of bone formation.
Minimal bone formation observed in: B – SS group, C – PDLSS group, D – DPSS group, ×40 magnification, Mason’s trichrome staining.
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the control group, which invariably is due to the unre-
sorbed silk fiber constructs at both 2 and 4 weeks. There
was no remarkable difference in the appearance of the
remaining silk fibers between the two time periods in all
groups, and histomorphometric analysis showed no sig-
nificant difference in the area of residual material be-
tween 2 and 4 weeks.
Discussion
Silk fibroin is a promising material due to its excellent
mechanical strength, biocompatibility and porous archi-
tecture to act as the artificial extracellular matrix re-
quired for 3D tissue engineering application. The
objectives of this study were to evaluate the efficacy of
silk fibroin constructs for the regeneration of bone de-
fects and determine the effect of the added cellular com-
ponents in vivo. The current experimental model has
previously been shown to be suitable for the evaluationFigure 5 Histological view of the groups at 4 weeks postoperatively.
group, C – PDLSS group, D – DPSS groups all display early bone formation at
Mason’s trichrome staining.of bone substitutes at the early stage of healing when
study periods of 2 and 4 weeks were combined [22].
Negligible amount of bone formation was noticed in the
defects of the control group at both 2 and 4 weeks as
the surrounding soft tissue structures appeared to have
collapsed into the defect spaces. The histomorphometric
analysis shows that all the experimental groups had
greater total augmented area than the control group at
both 2 and 4 weeks, however, no significant difference
was revealed in regards to the area of new bone between
the groups. This result indicates that the silk scaffold
was effective in maintaining the defect space for at least
4 weeks, but the addition of cellular components had no
effect in the amount of bone regeneration.
Silk fibroin scaffolds have been demonstrated to be
mechanically robust in previous studies [23,24]. In the
present study, the grafted volumes were well maintained
in all of the experimental groups which had led to new
bone formation occurring from the periphery of theA – Control group shows negligible amount of bone formation. B – SS
the periphery of the defects shown by the arrows. ×40 magnification,
Figure 6 Graphs showing total grafted area, new bone area, remaining material (mm2). A – after 2 weeks of healing, B – after 4 weeks of healing.
Table 1 Total grafted area, new bone area, remaining material at 2 and 4 weeks
Parameters (mm2) Control SS DPSS PDLSS
2 Weeks Total grafted area 6.2 ± 1.7 *11.66 ± 2.1 *12.46 ± 1.63 *10.68 ± 0.91
New bone area 1.13 ± 0.88 0.4 ± 0.13 0.84 ± 0.93 0.7 ± 0.5
Remaining material NA 3.9 ± 1.5 6.15 ± 2.5 5.77 ± 2.7
4 Weeks Total grafted area 7.63 ± 1.38 *15.47 ± 4.37 *13.28 ± 1.23 *13.35 ± 1.17
New bone area 1.37 ± 0.29 1.36 ± 0.47 0.67 ± 0.39 0.54 ± 1.23
Remaining material NA 4.61 ± 0.62 5.83 ± 1.27 5.29 ± 1.15
*Significantly different from the control (P < 0.05).
SS – silk scaffold.
DPSS – dental pulp cells with silk scaffold.
PDLSS – periodontal ligament cells with silk scaffold.
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tact with the fibrous bundles of the silk scaffold, and the
provisional collagen matrix seemed to surround the indi-
vidual silk fibers without any adverse reaction. This
histologic evidence demonstrates biocompatibility of the
silk fibroin in vivo to act as the osteoconductive basis for
bone regeneration. Silk fibroin is known for its biocom-
patibility and low immunogenicity following implant-
ation once rendered devoid of sericin, a glycosylated
protein emitting immunogenicity [25]. In vitro studies
have demonstrated that silk is enzymatically broken
down by a family of proteases directly into peptides and
amino acids, which indicates that the biodegradation
products of silk fibroin do less or no harm to the human
body [26]. In this study, inflammatory cells mainly mac-
rophages were found evenly distributed within the scaf-
fold at 2 weeks. However, no abnormal clinical findings
were observed during follow up of the animals, and the
inflammatory cells had completely vanished at 4 weeks
suggesting that this would have been part of the normal
wound healing sequence. Macrophages are known to
predominantly appear during the inflammatory phase of
the wound healing and contribute to inducing angiogen-
esis and laying down a new ECM. At 4 weeks, denser
collagenous provisional matrix was observed throughout
the scaffold, evident by the increased blue coloration
around the SF by the Masson’s trichrome staining and
formation of blood vessels around the fibrous bundles.
However, the vascular network failed to penetrate the
bundles of silk fibers. This could be due to the compact
organization of the fibrous bundles as well as the lack of
biodegradation of the material in order to accommodate
sufficient space for angiogenesis.
The silk fibroin constructs remained unresorbed after
4 weeks in this study. This is concurrent with previous
literature in which silk was demonstrated to be proteo-
lytically biodegraded and resorbed in vivo typically
within a year [26]. The slow biodegradation of silk may
be responsible for the small amount of bone formation
in all experimental groups, as new bone formation can-
not occur if the defect space is already occupied. In vivo
degradation kinetics of the silk scaffold should closely
match the functional needs and mechanical properties
specific to the defect type [27]. In consideration of slow
degradation, mechanical toughness and the pattern of
bone formation occurring from the periphery, SF con-
structs could be advantageously used in highly loaded
areas where cortical bridging and long-term support of
function is critical. In non-stress bearing defects such as
the one used for this study, long term support may not
be necessary but rather dynamic resorption of the im-
plant material and bone remodeling occurring synchron-
ously in a gradual substitution process [28]. Hence,
timely resorption of SS can be considered favorable inthe promotion of osteogenesis. It has been shown that
resorption rate of silk fibroin can be modulated by vary-
ing the pore size, crystallinity and molecular weight dis-
tribution [29]. Wang et al. have shown that the in vivo
behavior of silk fibroin can be predictably altered and
controlled to match the tissue-specific requirements of
the scaffold characteristics and resorption rates [30].
Furthermore, acid-degraded silk fibroin fragments with
low molecular weight has been shown to produce highly
osteogenic properties by inducing increases in ALP,
type-I collagen and fibronectin levels [31].
The present study incorporated the use of nHA-
coated silk fibroin. Although a control group containing
pure silk scaffold without nHA-coating may have dem-
onstrated potential benefits of the nHA-coating, the pri-
mary end point in the current study was to investigate
the effects of the addition of two cellular components in
osteogenesis. Furthermore, in vitro studies [32,33] have
demonstrated that nHA-coating on silk fibroin may im-
prove cytocompatibility compared to the pure silk fi-
broin. Fibrous substrates have been shown to support
cell attachment, proliferation and differentiation, while
the hydroxyapatite constituent promotes the secretion of
ECM for mineralization of new bone [34]. The degrad-
ation of nHA changes the Ca/P metabolism and triggers
the activation of osteoblasts [35]. The nHA particles
showed higher calcium release and increased osteoblast
attachment than the conventional sized HA. The SEM
appearance of the nHA crystals with overlying ECM is a
concurrent finding to the reports in previous studies. In
vitro study by Wei et al. [36] suggested that surface top-
ography had a crucial influence on cell behavior, which
was accompanied by attenuated proliferation rates on
rougher surfaces. Nevertheless, after 2 weeks of cultiva-
tion, cell number of osteoblasts on mineralized silk was
slightly higher than that on pure silk.
In the present study, the DPCs and PDLCs were cul-
tured and seeded onto the nHA-coated SF constructs for
3 weeks. It has been shown that pre-culture of cells on
silk scaffold prior to implantation improved the distribu-
tion of ECM mineralization due to better cell distribu-
tion within the scaffold [7]. Ideally, greater quantity of
ECM should be produced with a larger number of cells.
However, large cell numbers on silk scaffolds might be
counter-productive for cell-attachment due to limited
scaffold surface area. The cells were prepared according to
a coherent protocol to existing literatures, in which osteo-
blastic precursors were obtained in vitro, and successful
bone regeneration was achieved in vivo [11,12,20,37]. The
SEM observations of the silk fibroin constructs after cell
culture showed presence of the cellular components sur-
rounded by ECM.
The silk scaffold used in the present study contained
mean pore diameter of 65 μm. Due to scaffold shrinkage
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which would be reversible when scaffolds were again
placed in liquid. A previous study [7] demonstrated that
small scaffold pores with average pore diameters below
100 μm did not constrain medium penetration into the
middle of the scaffold, even in a static set-up. On the other
hand, the smallest pores (61.6 ± 5.0 μm) presented the lar-
gest growth surface to the cells and allowed better migra-
tion of cells to the inner most parts of the scaffold
resulting in more homogenous distribution of mineralized
tissue, despite the general belief that larger pores improve
cell and medium distribution.
However, histologically at 2 and 4 weeks in vivo, no
significant difference in the amount of bone formation
was observed in both DPSS and PDLSS groups com-
pared to the SS group. A possible explanation could be
that the proportion of stem cells within the cultured
population may not have been enough to produce a sig-
nificant impact on bone formation. The purity of the
stem cells could have been enriched by initial validation
of their ability to generate clonogenic cell clusters
in vitro followed by further isolation of the stem cells
using protocols such as magnetic bead cell separation
based on the expression of mesenchymal stem cell asso-
ciated markers [38].
In addition, xenogeneic cells of human origin were
transplanted into rabbits that were not immunocomprom-
ised. The lack of host-verses-graft response at the grafted
sites may be attributed to the initial scarcity of blood ves-
sels at the site of implantation as well as the isolated na-
ture of the contained-type defects in the calvaria. Had
allogeneic cells been used, it remains possible that greater
synergy might have been achieved. Previous studies have
shown that although xenogeneic supply of mesenchymal
stem cell (MSC) are likely to be rejected by the host after
transplantation, allogeneic MSCs are well-tolerated by the
recipient hosts [39]. DPSCs have also been shown to pos-
sess immunosuppressive effects [40].
Furthermore, it is impossible to verify in the present
study whether new bone originated from the grafted
cells or native cells. Future studies should employ cell la-
belling techniques to confirm that neo-osteogenesis de-
rived from the recruited hDPCs and hPDLCs rather
than the endogenous rabbit MSCs that could have mi-
grated to the defect site.
Conclusions
In summary, the results supported the biocompatibility of
nHA-coated silk and its potential usefulness as an osteo-
conductive scaffold. However, there is a lack of evidence
to suggest that using the current method of preparation,
hPDLCs and hDPCs can produce an early effect in bone
regeneration. Resorption rate of the silk fibroin should be
modulated in order to promote timely substitution of thesilk fibroin by living tissues. Further studies should be per-
formed using confirmed stem cell population with longer
healing periods for proper evaluation of its effects.
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